New modular implants aim to restore function after severe bone loss

NCT ID NCT07369778

Not yet recruiting Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Feb 01, 2026 · Last updated May 22, 2026 · Updated 17 times

Summary

This study will test a new line of modular prostheses (the Pantheon range) in 375 people who have lost large amounts of bone due to cancer, complex fractures, or failed previous surgeries. The implants are designed to be adjusted during surgery for a precise fit and include a special ring to help the bone grow into the implant. Researchers will track how long the implants last without needing another surgery and measure patients' function and quality of life for up to 5 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECONSTRUCTION OF MASSIVE BONE LOSS (ONCOLOGIC AND NON-ONCOLOGIC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU de Nantes

Nantes, 44093, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

RECONSTRUCTION OF MASSIVE BONE LOSS (ONCOLOGIC AND NON-ONCOLOGIC)